SCHEMBL7168459

SCHEMBL7168459

COc1ccc(CNc2nc(Cl)nc(NCCO)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 3/20 0.57
CCNE1 P24864 3/20 0.57
CDK2 P24941 3/20 0.57
ALDH1A1 P00352 1/20 0.56
MAPT P10636 2/20 0.56
PIK3CA P42336 1/20 0.54
GBA1 P04062 2/20 0.52
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
EGFR P00533 1/20 0.47
PRUNE1 Q86TP1 1/20 0.47
CLK1 P49759 1/20 0.47
CLK2 P49760 1/20 0.47
DYRK1A Q13627 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
DYRK1B Q9Y463 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888965 0.90 PIK3CA (0.62) CCNE2CCNE1CDK2MAPTPIK3CA
SCHEMBL2801822 0.87 PIK3CA (0.66) CCNE2CCNE1CDK2MAPTPIK3CA
SCHEMBL14810937 0.85 ALDH1A1 (0.78) ALDH1A1MAPTGBA1KMT2ASMN1; SMN2
SCHEMBL28736417 0.84 PIK3CA (0.57) CCNE2CCNE1CDK2ALDH1A1MAPT
SCHEMBL27221084 0.82 CCNE2 (0.71) CCNE2CCNE1CDK2ALDH1A1MAPT
SCHEMBL163906 0.81 PIK3CA (0.75) CCNE2CCNE1CDK2MAPTPIK3CA
SCHEMBL6335176 0.80 CA1 (0.57) ALDH1A1MAPTPIK3CASMN1; SMN2CYP1A2
SCHEMBL14810305 0.77 MAPT (0.69) ALDH1A1MAPTGBA1KMT2ASMN1; SMN2
SCHEMBL23431538 0.77 MAPT (0.48) CCNE2CCNE1CDK2ALDH1A1MAPT
SCHEMBL10359051 0.77 ALDH1A1 (0.89) ALDH1A1MAPTGBA1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6573377-B1 Antitumor agent capable of showing its efficacy even against 5- FU drug resistant tumors DAIICHI PHARMACEUTICALS CO., LTD. (JP) 2003-06-03 US disclosed
EP-1103551-A1 PYRAZOLE DERIVATIVES AND SALTS THEREOF DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-05-30 EP disclosed